follow us

follow us

Speakers

  1. Pharmacovigilance World 2024
  2. Speakers
  3. Jordi Casanellas

Jordi Casanellas


Head of Language AI - Bayer



Jordi Casanellas is Head of Language AI at Bayer Pharma IT. He drives innovative projects to realize the potential that Generative AI has to support and transform business processes across the pharmaceutical value chain, from R&D to Commercialization and Pharmacovigilance. Jordi has over 16 years of experience with data, science and engineering, first as astrophysics researcher and later as data science consultant, university professor, founder of an AI company, and leader



Jordi Casanellas

Sessions


  • Thursday - September 12, 2024 - 09:00

    Improving Drug Safety Through Adverse Event Detection with Natural Language Processing (NLP) and Generative AI

    • The transformative impact of Natural Language Processing (NLP) on the efficiency and accuracy of adverse event detection in pharmacovigilance.
    • How NLP techniques can convert unstructured textual data from sources like medical records, social media, and patient narratives into actionable insights for drug safety monitoring.
    • The challenges, such as data quality and privacy concerns, as well as the opportunities presented by NLP in improving drug safety, including early signal detection and more precise risk assessment.
      Presentation

  • Thursday - September 12, 2024 - 15:50

    Panel Discussion – Unleashing the Potential: Digital Transformation in Pharmacovigilance – Opportunities, Challenges and Future Directions

    • How artificial intelligence and machine learning are reshaping pharmacovigilance by enhancing signal detection, automating adverse event processing, and predicting potential risks.
    • The utilization of real-world data from sources such as electronic health records, social media, and wearables for more comprehensive and timely adverse event monitoring.
    • The role of digital technologies in improving patient engagement and reporting of adverse events, and the impact of patient-generated data on pharmacovigilance efforts.
    • Addressing the challenges related to data privacy, security, and compliance with evolving regulations in the context of digital transformation in pharmacovigilance.
    • The emerging trends, opportunities, and best practices in the ongoing digital transformation journey within the field of pharmacovigilance.

 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now